 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

JPMorgan Chase  Co. reaffirmed their neutral rating on shares of Afya (NASDAQ:AFYA  Free Report) in a research note released on Monday, Benzinga reports. JPMorgan Chase  Co...

Afya (NASDAQ:AFYA) Given "Neutral" Rating at JPMorgan Chase & Co.

Bank of Montreal Can acquired a new stake in shares of Afya Limited (NASDAQ:AFYA  Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities &#38...

Bank of Montreal Can Invests $524,000 in Afya Limited (NASDAQ:AFYA)

AFYA's total volume now sits at 793.3K. The +2.39% price change was insignificant, leaving IBM's price at $18.02...

The volume for Afya stock increased for one day, resulting in a record-breaking daily growth of 330% of the 65-Day Volume Moving Average

Afya Limited (AFYA) Q3 2023 Earnings Call Transcript...

Afya Limited (AFYA) Q3 2023 Earnings Call Transcript

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arcellx Inc (ACLX Research Report), Afya (AFYA...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcellx Inc (ACLX), Afya (AFYA) and Landos Biopharma (LABP)

This is a signal that AFYA's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Afya (AFYA, $17.6) RSI Indicator left the overbought zone on November 13, 2023

Over the last three days, A.I.dvisor has detected that AFYA's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Afya (AFYA, $17.6) Aroon Indicator entered an Uptrend on November 13, 2023.

Afya GAAP EPS of R$1.03, revenue of R$726.48M...

Afya GAAP EPS of R$1.03, revenue of R$726.48M

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (Afya or the Company), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for...

Afya Limited Announces Third Quarter and Nine Months 2023 Financial Results

Afya Ltd. is a medical education group, which engages in the provision of an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs, and continuing medical education activities. It operates through Education Services; and Digital Content, Residency Preparatory and Specialization Programs segments. The Education Services segment provides educational services through undergraduate and graduate courses related to medicine, other health sciences, and other undergraduate programs. The Residency Preparatory and Specialization Programs segment offers digital and printed medical content services, including online courses for residency preparatory, medical and other than medical post-graduate specialization programs and mobile app subscription for digital medical content. The company was founded on March 22, 2019 and is headquartered in Nova Lima, Brazil.

Market Cap	$1.96B
Volume (M)	202,925.00
52-Wk High	$21.91
52-Wk Low	$9.66

AFYA Afya Ltd - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community